Kristen J. Vogel Postula

Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing

Lisa R. Susswein, Megan L. Marshall, Rachel Nusbaum et al. · Genetics in Medicine · 2015 · 288 citations · Full text

Medicine, Genetics, Oncology +17

Cancer Genetic Counseling and Testing in an Era of Rapid Change

Gillian W. Hooker, Keelia Rhoads Clemens, John M. Quillin et al. · Journal of Genetic Counseling · 2017 · 40 citations · Full text

Life Sciences, Counseling, Genetics +13

Monoallelic MUTYH pathogenic variants ascertained via multi-gene hereditary cancer panels are not associated with colorectal, endometrial, or breast cancer

Amanda Thompson, Erin G. Sutcliffe, Kevin J. Arvai et al. · Familial Cancer · 2022 · 28 citations

Life Sciences, Genetics, Molecular Genetics +16

FDA Approval of PARP Inhibitors and the Impact on Genetic Counseling and Genetic Testing Practices

Kathryn M. Buchtel, Kristen J. Vogel Postula, Shelly M. Weiss et al. · Journal of Genetic Counseling · 2017 · 22 citations · Full text

Life Sciences, Genetics, Oncology +13

Apparently Heterozygous TP53 Pathogenic Variants May Be Blood Limited in Patients Undergoing Hereditary Cancer Panel Testing

Jessica L. Mester, Sarah A. Jackson, Kristen J. Vogel Postula et al. · Journal of Molecular Diagnostics · 2019 · 22 citations · Full text

Medicine, Genetics, Molecular Genetics +12